Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 1;97(1):217–225. doi: 10.1172/JCI118393

Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.

C P Delaney 1, N Murase 1, M Chen-Woan 1, J J Fung 1, T E Starzl 1, A J Demetris 1
PMCID: PMC507082  PMID: 8550837

Abstract

Conventional allogeneic bone marrow transplantation after myeloablation can prevent experimental autoimmunity and has been proposed as treatment for humans. However, trace populations of donor hematolymphoid cells persisting in solid organ allograft recipients have been associated in some circumstances with therapeutic effects similar to replacement of the entire bone marrow. We therefore examined whether inducing hematolymphoid microchimerism without myeloablation could confer the ability to resist mercuric chloride (HgCl2)-induced autoimmunity. Brown-Norway (BN) rats were pretreated with a syngeneic or allogeneic bone marrow infusion under transient FK506 immunosuppression before receiving HgCl2. They were compared with BN rats receiving either no pretreatment (naive) or FK506 alone. Administration of HgCl2 to naive BN rats induced marked autoantibody production, systemic vasculitis and lymphocytic infiltration of the kidneys, liver and skin in all of the animals and a 47% mortality. In contrast, BN rats pretreated with HgCl2-resistant allogeneic Lewis bone marrow and transient FK506 showed less clinical disease and were completely protected from mortality. More specifically, IgG anti-laminin autoantibody production was decreased by 40% (P < 0.05), and there was less histopathological tissue injury (P < 0.005), less in vitro autoreactivity (P < 0.05), less of an increase in class II MHC expression on B cells (P < 0.01), and 22% less weight loss (P < 0.01), compared with controls. Protection from the experimental autoimmunity was associated with signs of low grade activation of the BN immune system, which included: increased numbers of circulating B and activated T cells before administration of HgCl2, and less autoreactivity and spontaneous proliferation in vitro after HgCl2.

Full Text

The Full Text of this article is available as a PDF (700.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Elmagd K., Todo S., Tzakis A., Reyes J., Nour B., Furukawa H., Fung J. J., Demetris A., Starzl T. E. Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994 Oct;179(4):385–400. [PMC free article] [PubMed] [Google Scholar]
  2. BILLINGHAM R. E., BRENT L., MEDAWAR P. B. Actively acquired tolerance of foreign cells. Nature. 1953 Oct 3;172(4379):603–606. doi: 10.1038/172603a0. [DOI] [PubMed] [Google Scholar]
  3. Balan V., Batts K. P., Porayko M. K., Krom R. A., Ludwig J., Wiesner R. H. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology. 1993 Dec;18(6):1392–1398. [PubMed] [Google Scholar]
  4. Bandeira A., Coutinho A., Carnaud C., Jacquemart F., Forni L. Transplantation tolerance correlates with high levels of T- and B-lymphocyte activity. Proc Natl Acad Sci U S A. 1989 Jan;86(1):272–276. doi: 10.1073/pnas.86.1.272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bellon B., Capron M., Druet E., Verroust P., Vial M. C., Sapin C., Girard J. F., Foidart J. M., Mahieu P., Druet P. Mercuric chloride induced autoimmune disease in Brown-Norway rats: sequential search for anti-basement membrane antibodies and circulating immune complexes. Eur J Clin Invest. 1982 Apr;12(2):127–133. doi: 10.1111/j.1365-2362.1982.tb00949.x. [DOI] [PubMed] [Google Scholar]
  6. Cavanaugh J., Chopek M., Binimelis J., Leiva A., Barbosa J. Buffy coat transfusions in early type I diabetes. Diabetes. 1987 Oct;36(10):1089–1093. doi: 10.2337/diab.36.10.1089. [DOI] [PubMed] [Google Scholar]
  7. Comenzo R. L., Malachowski M. E., Rohrer R. J., Freeman R. B., Rabson A., Berkman E. M. Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med. 1992 Mar 26;326(13):867–870. doi: 10.1056/NEJM199203263261305. [DOI] [PubMed] [Google Scholar]
  8. Coutinho A. Beyond clonal selection and network. Immunol Rev. 1989 Aug;110:63–87. doi: 10.1111/j.1600-065x.1989.tb00027.x. [DOI] [PubMed] [Google Scholar]
  9. Demetris A. J., Murase N., Fujisaki S., Fung J. J., Rao A. S., Starzl T. E. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec;25(6):3337–3344. [PMC free article] [PubMed] [Google Scholar]
  10. Dubey C., Bellon B., Hirsch F., Kuhn J., Vial M. C., Goldman M., Druet P. Increased expression of class II major histocompatibility complex molecules on B cells in rats susceptible or resistant to HgCl2-induced autoimmunity. Clin Exp Immunol. 1991 Oct;86(1):118–123. doi: 10.1111/j.1365-2249.1991.tb05783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Glazier A., Tutschka P. J., Farmer E. R., Santos G. W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983 Jul 1;158(1):1–8. doi: 10.1084/jem.158.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldman M., Abramowicz D., Lambert P., Vandervorst P., Bruyns C., Toussaint C. Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice. Clin Exp Immunol. 1988 Apr;72(1):79–83. [PMC free article] [PubMed] [Google Scholar]
  13. Harrison J. D., Mirza D. F., Gunson B. K., Mayer A. D., Buckels J. A., McMaster P. Development of indications and results during 10 years of orthotopic liver transplantation. Clin Transpl. 1993:153–160. [PubMed] [Google Scholar]
  14. Hess A. D., Jones R. C., Santos G. W. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect. Bone Marrow Transplant. 1993;12 (Suppl 3):S65–S69. [PubMed] [Google Scholar]
  15. Hubscher S. G., Elias E., Buckels J. A., Mayer A. D., McMaster P., Neuberger J. M. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol. 1993 Jun;18(2):173–184. doi: 10.1016/s0168-8278(05)80244-2. [DOI] [PubMed] [Google Scholar]
  16. Ikehara S., Good R. A., Nakamura T., Sekita K., Inoue S., Oo M. M., Muso E., Ogawa K., Hamashima Y. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2483–2487. doi: 10.1073/pnas.82.8.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KIRKPATRICK C. H., WILSON W. E., TALMAGE D. W. IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA. J Exp Med. 1964 May 1;119:727–742. doi: 10.1084/jem.119.5.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kuttler B., Mathieu C., Waer M., Hahn H. J., Bouillon R. Lack of disease recurrence in diabetic BB/Pfd rats after syngeneic islet transplantation. Autoimmunity. 1993;15(2):107–112. doi: 10.3109/08916939309043885. [DOI] [PubMed] [Google Scholar]
  19. Liegeois A., Charreire J., Brennan L. B. Allograft enhancement induced by bone marrow cells. Surg Forum. 1974;25(0):297–300. [PubMed] [Google Scholar]
  20. Liégeois A., Escourrou J., Ouvré E., Charreire J. Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc. 1977 Mar;9(1):273–276. [PubMed] [Google Scholar]
  21. Marmont A. M. Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases? Stem Cells. 1994 Jan;12(1):125–135. doi: 10.1002/stem.5530120119. [DOI] [PubMed] [Google Scholar]
  22. Martin R., McFarland H. F., McFarlin D. E. Immunological aspects of demyelinating diseases. Annu Rev Immunol. 1992;10:153–187. doi: 10.1146/annurev.iy.10.040192.001101. [DOI] [PubMed] [Google Scholar]
  23. Mathieson P. W. Mercuric chloride-induced autoimmunity. Autoimmunity. 1992;13(3):243–247. doi: 10.3109/08916939209004830. [DOI] [PubMed] [Google Scholar]
  24. Mathieson P. W., Stapleton K. J., Oliveira D. B., Lockwood C. M. Immunoregulation of mercuric chloride-induced autoimmunity in Brown Norway rats: a role for CD8+ T cells revealed by in vivo depletion studies. Eur J Immunol. 1991 Sep;21(9):2105–2109. doi: 10.1002/eji.1830210919. [DOI] [PubMed] [Google Scholar]
  25. McCarthy S. A., Cacchione R. N., Mainwaring M. S., Cairns J. S. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation. 1992 Sep;54(3):543–547. doi: 10.1097/00007890-199209000-00029. [DOI] [PubMed] [Google Scholar]
  26. Merino J., Schurmans S., Luzuy S., Izui S., Vassalli P., Lambert P. H. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies. J Immunol. 1987 Sep 1;139(5):1426–1431. [PubMed] [Google Scholar]
  27. Miller S. D., Tan L. J., Pope L., McRae B. L., Karpus W. J. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis. Int Rev Immunol. 1992;9(3):203–222. doi: 10.3109/08830189209061791. [DOI] [PubMed] [Google Scholar]
  28. Murase N., Starzl T. E., Tanabe M., Fujisaki S., Miyazawa H., Ye Q., Delaney C. P., Fung J. J., Demetris A. J. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 1995 Jul 27;60(2):158–171. doi: 10.1097/00007890-199507000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nalesnik M. A., Todo S., Murase N., Gryzan S., Lee P. H., Makowka L., Starzl T. E. Toxicology of FK-506 in the Lewis rat. Transplant Proc. 1987 Oct;19(5 Suppl 6):89–92. [PMC free article] [PubMed] [Google Scholar]
  30. Nossent H. C., Swaak T. J., Berden J. H. Systemic lupus erythematosus after renal transplantation: patient and graft survival and disease activity. The Dutch Working Party on Systemic Lupus Erythematosus. Ann Intern Med. 1991 Feb 1;114(3):183–188. doi: 10.7326/0003-4819-114-3-183. [DOI] [PubMed] [Google Scholar]
  31. Pelletier L., Pasquier R., Rossert J., Vial M. C., Mandet C., Druet P. Autoreactive T cells in mercury-induced autoimmunity. Ability to induce the autoimmune disease. J Immunol. 1988 Feb 1;140(3):750–754. [PubMed] [Google Scholar]
  32. Qian S., Demetris A. J., Murase N., Rao A. S., Fung J. J., Starzl T. E. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr;19(4):916–924. doi: 10.1002/hep.1840190418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H., Cyopick P., Danska J. S., Delovitch T. L. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med. 1993 Jul 1;178(1):87–99. doi: 10.1084/jem.178.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rossert J., Pelletier L., Pasquier R., Druet P. Autoreactive T cells in mercury-induced autoimmunity. Demonstration by limiting dilution analysis. Eur J Immunol. 1988 Nov;18(11):1761–1766. doi: 10.1002/eji.1830181116. [DOI] [PubMed] [Google Scholar]
  35. Rossini A. A., Mordes J. P., Greiner D. L., Nakano K., Appel M. C., Handler E. S. Spleen cell transfusion in the Bio-Breeding/Worcester rat. Prevention of diabetes, major histocompatibility complex restriction, and long-term persistence of transfused cells. J Clin Invest. 1986 Apr;77(4):1399–1401. doi: 10.1172/JCI112448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schurmans S., Heusser C. H., Qin H. Y., Merino J., Brighouse G., Lambert P. H. In vivo effects of anti-IL-4 monoclonal antibody on neonatal induction of tolerance and on an associated autoimmune syndrome. J Immunol. 1990 Oct 15;145(8):2465–2473. [PubMed] [Google Scholar]
  37. Sibley R. K., Sutherland D. E. Pancreas transplantation. An immunohistologic and histopathologic examination of 100 grafts. Am J Pathol. 1987 Jul;128(1):151–170. [PMC free article] [PubMed] [Google Scholar]
  38. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C., Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992 Jun 27;339(8809):1579–1582. doi: 10.1016/0140-6736(92)91840-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Starzl T. E., Demetris A. J., Murase N., Thomson A. W., Trucco M., Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today. 1993 Jun;14(6):326–332. doi: 10.1016/0167-5699(93)90054-o. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Starzl T. E., Demetris A. J., Trucco M., Murase N., Ricordi C., Ildstad S., Ramos H., Todo S., Tzakis A., Fung J. J. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun;17(6):1127–1152. [PMC free article] [PubMed] [Google Scholar]
  41. Starzl T. E., Todo S., Tzakis A., Alessiani M., Casavilla A., Abu-Elmagd K., Fung J. J. The many faces of multivisceral transplantation. Surg Gynecol Obstet. 1991 May;172(5):335–344. [PMC free article] [PubMed] [Google Scholar]
  42. Takai K., Tokuda N., Sawada T., Fujikura Y., Jojima K., Sakatoku J., Fukumoto T. Effects of FK506 on rat thymic epithelial cells; immunohistochemical study. Thymus. 1992 Jun;19(4):207–217. [PubMed] [Google Scholar]
  43. Ward L. A., Jelveh Z., Feinfeld D. A. Recurrent membranous lupus nephritis after renal transplantation: a case report and review of the literature. Am J Kidney Dis. 1994 Feb;23(2):326–329. doi: 10.1016/s0272-6386(12)80992-9. [DOI] [PubMed] [Google Scholar]
  44. Wright H. L., Bou-Abboud C. F., Hassanein T., Block G. D., Demetris A. J., Starzl T. E., Van Thiel D. H. Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation. 1992 Jan;53(1):136–139. doi: 10.1097/00007890-199201000-00027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES